"Designing Growth Strategies is in our DNA"

Myasthenia Gravis Treatment Market Size, Share & Industry Impact Analysis, By Drug Class (Cholinesterase Inhibitors, Corticosteroids, Immunosuppressants, IVIg, and Monoclonal Antibodies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI106405

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Key Industry Developments (Mergers, Acquisitions, and Partnership)
    2. New Product Launches, by Key Players
    3. Impact of COVID-19 on the Market
  5. Global Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. North America Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Drug Class
      2. Canada
        1. By Drug Class
  7. Europe Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
        1. By Drug Class
      2. Germany
        1. By Drug Class
      3. France
        1. By Drug Class
      4. Spain
        1. By Drug Class
      5. Italy
        1. By Drug Class
      6. Scandinavia
        1. By Drug Class
      7. Rest of Europe
        1. By Drug Class
  8. Asia Pacific Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
        1. By Drug Class
      2. China
        1. By Drug Class
      3. India
        1. By Drug Class
      4. Australia
        1. By Drug Class
      5. Rest of Asia Pacific
        1. By Drug Class
  9. Rest of World Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. AstraZeneca
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Astellas Pharma Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Veloxis Pharmaceuticals, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Bausch Health Companies Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Key Industry Developments (Mergers, Acquisitions, and Partnership)
    2. New Product Launches, by Key Players
    3. Impact of COVID-19 on the Market
  5. Global Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. North America Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Drug Class
      2. Canada
        1. By Drug Class
  7. Europe Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
        1. By Drug Class
      2. Germany
        1. By Drug Class
      3. France
        1. By Drug Class
      4. Spain
        1. By Drug Class
      5. Italy
        1. By Drug Class
      6. Scandinavia
        1. By Drug Class
      7. Rest of Europe
        1. By Drug Class
  8. Asia Pacific Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
        1. By Drug Class
      2. China
        1. By Drug Class
      3. India
        1. By Drug Class
      4. Australia
        1. By Drug Class
      5. Rest of Asia Pacific
        1. By Drug Class
  9. Rest of World Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressants
      4. IVIg
      5. Monoclonal Antibodies
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. AstraZeneca
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Astellas Pharma Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Veloxis Pharmaceuticals, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Bausch Health Companies Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Myasthenia Gravis Treatment Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2025 & 2034

Figure 3: Global Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 4: Global Myasthenia Gravis Treatment Market Value (USD billion), by Region, 2025 & 2034

Figure 5: North America Myasthenia Gravis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 6: North America Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2025

Figure 7: North America Myasthenia Gravis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 8: North America Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 9: North America Myasthenia Gravis Treatment Market Value (USD billion), By Country, 2025 & 2034

Figure 10: North America Myasthenia Gravis Treatment Market Value Share (%), By Country, 2025

Figure 11: Europe Myasthenia Gravis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 12: Europe Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2025

Figure 13: Europe Myasthenia Gravis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 14: Europe Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 15: Europe Myasthenia Gravis Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 16: Europe Myasthenia Gravis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 17: Asia Pacific Myasthenia Gravis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 18: Asia Pacific Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2025

Figure 19: Asia Pacific Myasthenia Gravis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 20: Asia Pacific Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 21: Asia Pacific Myasthenia Gravis Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 22: Asia Pacific Myasthenia Gravis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 23: Rest of World Myasthenia Gravis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 24: Rest of World Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2025

Figure 25: Rest of World Myasthenia Gravis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 26: Rest of World Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 27: Global Myasthenia Gravis Treatment Market Share (%), By Company, 2025

Table 1: Global Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 2: Global Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 3: Global Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 4: North America Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 5: North America Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 6: North America Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 7: U.S. Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 8: Canada Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 9: Europe Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 10: Europe Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 11: Europe Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 12: Germany Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 13: U.K. Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 14: France Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 15: Italy Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 16: Spain Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 17: Scandinavia Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 18: Rest of Europe Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 19: Asia Pacific Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 20: Asia Pacific Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 21: Asia Pacific Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 22: Japan Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 23: India Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 24: China Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 25: Australia Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 26: Rest of Asia Pacific Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 27: Rest of World Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 28: Rest of World Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Myasthenia Gravis Treatment Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 147
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports